06:05 EDT Kairos Pharma (KAPA) files to sell 16.29M shares of common stock for holders
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KAPA:
- Kairos Pharma: Promising Oncology Pipeline and Strategic Advancements Drive Buy Rating
- Kairos Pharma: Promising Innovations in Cancer Drug Resistance and Immune Enhancement
- Block upgraded, Nvidia downgraded: Wall Street’s top analyst calls
- Kairos Pharma initiated with a Buy at H.C. Wainwright
- Promising Developments and Strategic Trials Propel Kairos Pharma’s Buy Rating